Ionis Pharmaceuticals (IONS)
(Delayed Data from NSDQ)
$41.83 USD
-0.93 (-2.17%)
Updated Sep 23, 2024 03:59 PM ET
After-Market: $41.84 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Price, Consensus and EPS Surprise
IONS 41.83 -0.93(-2.17%)
Will IONS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for IONS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for IONS
Ionis Stock Drops 12% on Pricing of $500M Common Stock Offering
Why Is Zoetis (ZTS) Up 1.4% Since Last Earnings Report?
IONS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Biogen's Phase II/III SMA Study for Higher Spinraza Dose Meets Goals
Theravance Bio (TBPH) Up 2.2% Since Last Earnings Report: Can It Continue?
How Should You Play AstraZeneca (AZN) After Q2 Beat, View Raise?
Other News for IONS
January 2027 Options Now Available For Ionis Pharmaceuticals (IONS)
Stock moves reflect downgrade for US economic growth outlook - Goldman
January 2026 Options Now Available For Ionis Pharmaceuticals
Biotech Alert: Searches spiking for these stocks today
Biotech Alert: Searches spiking for these stocks today